Stockreport

LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates [Yahoo! Finance]

LENZ Therapeutics, Inc.  (LENZ) 
PDF Capstone data from Phase 3 CLARITY study to be presented at Key Opinion Leader event planned for June 18, 2024 Completed merger with Graphite Bio and concurrent $53.5 [Read more]